For example, Ambrosini et al. demonstrated that NF-κB signaling was significantly activated in BETi-resistant melanoma cells and that inhibition of NF-κB signaling enhanced BET inhibitor sensitivity in melanoma34. The gene discussed is NFKB1; the disease is melanoma.